InsidersTradesSigma
Track the IMAGION BIOSYSTEMS LIMITED stock price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €6.4m. The latest transaction was filed on 25 August 2026 (Purchase). Among the most active insiders: Robert Romeo Proulx. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
IMAGION BIOSYSTEMS LIMITED is a company listed on the XASX, specializing in the development of medical imaging technologies. It focuses on innovative solutions for the early diagnosis of cancer.